Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Dolutegravir Sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

61 API Suppliers, 27 USDMF, 12 EU WC, 2 KDMF, 12 NDC API, 36 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

154 Drugs in Development

154 Drugs in Development

INTERMEDIATES

40 Intermediate Suppliers

40 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

134 FDF Dossiers, 30 FDA Orange Book, 27 Europe, 5 Canada, 4 Australia, 63 South Africa, 5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 50MG BASE, TABLET;ORAL - EQ 600MG BASE;EQ 50MG BASE;300MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Rochem International Inc, 15 SPI Pharma, 3 DKSH, 4 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 1 Kirsch Pharma, 3 Actylis, 1 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 20 BASF, 5 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 1 Finar, 7 Gangwal Chemicals, 2 Ideal Cures, 2 Ingredion Pharma Solutions, 14 Kerry, 2 Keval Exports, 12 Microlex e.U, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 13 Roquette, 2 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

56 Fillers, Diluents & Binders, 25 Direct Compression, 22 Granulation, 20 Coating Systems & Additives, 20 Disintegrants & Superdisintegrants, 18 Lubricants & Glidants, 16 Solubilizers, 15 Controlled & Modified Release, 15 Chewable & Orodispersible Aids, 15 Thickeners and Stabilizers, 12 Co-Processed Excipients, 12 Taste Masking, 11 Parenteral, 11 Topical, 5 Film Formers & Plasticizers, 3 Surfactant & Foaming Agents, 3 Coloring Agents, 2 Rheology Modifiers, 2 Emulsifying Agents, 2 API Stability Enhancers

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 128 News #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 7 Regulatory FDF Prices, 58 Annual Reports

MARKET PLACE

10 APIs, 8 FDF Dossiers

PATENTS & EXCLUSIVITIES

36 US Patents, 5 US Exclusivities, 17 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
31/10/2025	GSK	United Kingdom	GlaxoSmithKline Inc.	Su231-19-ND	Dolutegravir sodium	2020-08-13	Glaxo Wellcome Manufacturing Pte. Ltd@[Micronized Manufacturing Plant] Catalent Micron Technologies Limited	United Kingdom	1 Pioneer Sector 1, Singapore 628413@[Micronising Manufactory]Crossways Boulevard, Crossways, Dartford, DA2 6QY, United Kingdom
31/10/2025	Shionogi	Japan	GlaxoSmithKline Inc.	Su2480-14-ND	Dolutegravir sodium (micronized)	2014-08-01	Shionogi Pharma Co., Ltd.@[Some process manufacturers] Fujimoto Chemicals Co., Ltd. Senboku Plant	Japan	224-20, Hiraishiebisuno, Kawauchi-cho, Tokushima, Tokushima 771-0132, Japan@1-24, Rinkai-cho, Izumiohtsu-shi, Osaka 595-0075, Japan

Dolutegravir Sodium

Dolutegravir Sodium

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

61 API Suppliers

27 USDMF

12 EU WC

2 KDMF

12 NDC API

36 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

154 Drugs in Development

INTERMEDIATES

40 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

134 FDF Dossiers

30 FDA Orange Book

27 Europe

5 Canada

4 Australia

63 South Africa

5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 50MG BASE

TABLET;ORAL - EQ 600MG BASE;EQ 50MG BASE;300MG

RELATED EXCIPIENT COMPANIES

1 Minakem

1 Rochem International Inc

15 SPI Pharma

3 DKSH

4 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Pfanstiehl

1 Kirsch Pharma

3 Actylis

1 Aeon Procare

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

20 BASF

5 Corel Pharma Chem

5 DFE Pharma

1 Esteem Industries

1 Finar

7 Gangwal Chemicals

2 Ideal Cures

2 Ingredion Pharma Solutions

14 Kerry

2 Keval Exports

12 Microlex e.U

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

3 Pharmatrans-Sanaq

5 Pluviaendo

3 Prachin Chemical

13 Roquette

2 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

10 Sigachi Industries

3 Silverline Chemicals

1 Ulanqab Kema New Material

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

56 Fillers, Diluents & Binders

25 Direct Compression

22 Granulation

20 Coating Systems & Additives

20 Disintegrants & Superdisintegrants

18 Lubricants & Glidants

16 Solubilizers

TABLET;ORAL - EQ 10MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 25MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons